A Detailed Analysis of the Rat Model Market Based on Genetic Advancements and Increasing Preclinical Research Demands
Report ID: PMRREP33949
Number of Pages: 211
Format: PPT*, PDF, EXCEL
Industry: Healthcare
Published Date: January-2024
1. Executive Summary
1.1. Global Rat Model Market Snapshot, 2023 and 2030
1.2. Market Opportunity Assessment, 2023 - 2030, US$ Mn
1.3. Key Market Trends
1.4. Future Market Projections
1.5. Premium Market Insights
1.6. Industry Developments and Key Market Events
1.7. PMR Analysis and Recommendations
2. Market Overview
2.1. Market Scope and Definition
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Opportunity
2.2.4. Challenges
2.2.5. Key Trends
2.3. Type Lifecycle Analysis
2.4. Rat Model Market: Value Chain
2.4.1. List of Raw Material Supplier
2.4.2. List of Manufacturers
2.4.3. List of Distributors
2.4.4. List of Applications
2.4.5. Profitability Analysis
2.5. Porter Five Force's Analysis
2.6. Geopolitical Tensions: Market Impact
2.7. Macro-Economic Factors
2.7.1. Global Sectorial Outlook
2.7.2. Global GDP Growth Outlook
2.7.3. Global Parent Market Overview
2.8. Forecast Factors - Relevance and Impact
2.9. Regulatory and Technology Landscape
3. Global Rat Model Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
3.1. Key Highlights
3.1.1. Market Volume (Units) Projections
3.1.2. Market Size and Y-o-Y Growth
3.1.3. Absolute $ Opportunity
3.2. Market Size (US$ Mn) Analysis and Forecast
3.2.1. Historical Market Size Analysis, 2013-2016
3.2.2. Current Market Size Forecast, 2018-2026
3.3. Global Rat Model Market Outlook: Type
3.3.1. Introduction / Key Findings
3.3.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Type, 2018 - 2022
3.3.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Type, 2023 - 2030
3.3.3.1. Knockout
3.3.3.2. Outbred
3.3.3.3. Inbred
3.3.3.4. Hybrid
3.3.3.5. Immunodeficient
3.3.3.6. Conditioned
3.4. Market Attractiveness Analysis: Type
3.5. Global Rat Model Market Outlook: Technology
3.5.1. Introduction / Key Findings
3.5.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Technology, 2018 - 2022
3.5.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Technology, 2023 - 2030
3.5.3.1. Nuclear Transferase
3.5.3.2. Microinjection
3.5.3.3. Embryonic Stem Cell
3.5.3.4. Others
3.6. Market Attractiveness Analysis: Technology
3.7. Global Rat Model Market Outlook: Application
3.7.1. Introduction / Key Findings
3.7.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Application, 2018 - 2022
3.7.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
3.7.3.1. Oncology
3.7.3.2. Neurology
3.7.3.3. Immunology
3.7.3.4. Toxicology
3.7.3.5. Other
3.8. Market Attractiveness Analysis: Application
3.9. Global Rat Model Market Outlook: End User
3.9.1. Introduction / Key Findings
3.9.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By End User, 2018 - 2022
3.9.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
3.9.3.1. CROs
3.9.3.2. Academic and Research Institutes
3.9.3.3. Pharmaceutical & Biotechnology Companies
3.10. Market Attractiveness Analysis: End User
4. Global Rat Model Market Outlook: Region
4.1. Key Highlights
4.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Region, 2018 - 2022
4.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Region, 2023 - 2030
4.3.1. North America
4.3.2. Europe
4.3.3. East Asia
4.3.4. South Asia and Oceania
4.3.5. Latin America
4.3.6. Middle East & Africa (MEA)
4.4. Market Attractiveness Analysis: Region
5. North America Rat Model Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
5.1. Key Highlights
5.2. Pricing Analysis
5.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
5.3.1. By Country
5.3.2. By Type
5.3.3. By Technology
5.3.4. By Application
5.3.5. By End User
5.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
5.4.1. U.S.
5.4.2. Canada
5.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Type, 2023 - 2030
5.5.1. Knockout
5.5.2. Outbred
5.5.3. Inbred
5.5.4. Hybrid
5.5.5. Immunodeficient
5.5.6. Conditioned
5.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Technology, 2023 - 2030
5.6.1. Nuclear Transferase
5.6.2. Microinjection
5.6.3. Embryonic Stem Cell
5.6.4. Others
5.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
5.7.1. Oncology
5.7.2. Neurology
5.7.3. Immunology
5.7.4. Toxicology
5.7.5. Other
5.8. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
5.8.1. CROs
5.8.2. Academic and Research Institutes
5.8.3. Pharmaceutical & Biotechnology Companies
5.9. Market Attractiveness Analysis
6. Europe Rat Model Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
6.1. Key Highlights
6.2. Pricing Analysis
6.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
6.3.1. By Country
6.3.2. By Type
6.3.3. By Technology
6.3.4. By Application
6.3.5. By End User
6.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
6.4.1. Germany
6.4.2. France
6.4.3. U.K.
6.4.4. Italy
6.4.5. Spain
6.4.6. Russia
6.4.7. T rkiye
6.4.8. Rest of Europe
6.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Type, 2023 - 2030
6.5.1. Knockout
6.5.2. Outbred
6.5.3. Inbred
6.5.4. Hybrid
6.5.5. Immunodeficient
6.5.6. Conditioned
6.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Technology, 2023 - 2030
6.6.1. Nuclear Transferase
6.6.2. Microinjection
6.6.3. Embryonic Stem Cell
6.6.4. Others
6.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
6.7.1. Oncology
6.7.2. Neurology
6.7.3. Immunology
6.7.4. Toxicology
6.7.5. Other
6.8. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
6.8.1. CROs
6.8.2. Academic and Research Institutes
6.8.3. Pharmaceutical & Biotechnology Companies
6.9. Market Attractiveness Analysis
7. East Asia Rat Model Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
7.1. Key Highlights
7.2. Pricing Analysis
7.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
7.3.1. By Country
7.3.2. By Type
7.3.3. By Technology
7.3.4. By Application
7.3.5. By End User
7.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
7.4.1. China
7.4.2. Japan
7.4.3. South Korea
7.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Type, 2023 - 2030
7.5.1. Knockout
7.5.2. Outbred
7.5.3. Inbred
7.5.4. Hybrid
7.5.5. Immunodeficient
7.5.6. Conditioned
7.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Technology, 2023 - 2030
7.6.1. Nuclear Transferase
7.6.2. Microinjection
7.6.3. Embryonic Stem Cell
7.6.4. Others
7.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
7.7.1. Oncology
7.7.2. Neurology
7.7.3. Immunology
7.7.4. Toxicology
7.7.5. Other
7.8. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
7.8.1. CROs
7.8.2. Academic and Research Institutes
7.8.3. Pharmaceutical & Biotechnology Companies
7.9. Market Attractiveness Analysis
8. South Asia & Oceania Rat Model Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
8.1. Key Highlights
8.2. Pricing Analysis
8.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
8.3.1. By Country
8.3.2. By Type
8.3.3. By Technology
8.3.4. By Application
8.3.5. By End User
8.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
8.4.1. India
8.4.2. Southeast Asia
8.4.3. ANZ
8.4.4. Rest of South Asia & Oceania
8.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Type, 2023 - 2030
8.5.1. Knockout
8.5.2. Outbred
8.5.3. Inbred
8.5.4. Hybrid
8.5.5. Immunodeficient
8.5.6. Conditioned
8.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Technology, 2023 - 2030
8.6.1. Nuclear Transferase
8.6.2. Microinjection
8.6.3. Embryonic Stem Cell
8.6.4. Others
8.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
8.7.1. Oncology
8.7.2. Neurology
8.7.3. Immunology
8.7.4. Toxicology
8.7.5. Other
8.8. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
8.8.1. CROs
8.8.2. Academic and Research Institutes
8.8.3. Pharmaceutical & Biotechnology Companies
8.9. Market Attractiveness Analysis
9. Latin America Rat Model Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
9.1. Key Highlights
9.2. Pricing Analysis
9.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
9.3.1. By Country
9.3.2. By Type
9.3.3. By Technology
9.3.4. By Application
9.3.5. By End User
9.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
9.4.1. Brazil
9.4.2. Mexico
9.4.3. Rest of Latin America
9.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Type, 2023 - 2030
9.5.1. Knockout
9.5.2. Outbred
9.5.3. Inbred
9.5.4. Hybrid
9.5.5. Immunodeficient
9.5.6. Conditioned
9.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Technology, 2023 - 2030
9.6.1. Nuclear Transferase
9.6.2. Microinjection
9.6.3. Embryonic Stem Cell
9.6.4. Others
9.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
9.7.1. Oncology
9.7.2. Neurology
9.7.3. Immunology
9.7.4. Toxicology
9.7.5. Other
9.8. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
9.8.1. CROs
9.8.2. Academic and Research Institutes
9.8.3. Pharmaceutical & Biotechnology Companies
9.9. Market Attractiveness Analysis
10. Middle East & Africa Rat Model Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
10.1. Key Highlights
10.2. Pricing Analysis
10.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
10.3.1. By Country
10.3.2. By Type
10.3.3. By Technology
10.3.4. By Application
10.3.5. By End User
10.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
10.4.1. GCC
10.4.2. Egypt
10.4.3. South Africa
10.4.4. Northern Africa
10.4.5. Rest of Middle East & Africa
10.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Type, 2023 - 2030
10.5.1. Knockout
10.5.2. Outbred
10.5.3. Inbred
10.5.4. Hybrid
10.5.5. Immunodeficient
10.5.6. Conditioned
10.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Technology, 2023 - 2030
10.6.1. Nuclear Transferase
10.6.2. Microinjection
10.6.3. Embryonic Stem Cell
10.6.4. Others
10.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
10.7.1. Oncology
10.7.2. Neurology
10.7.3. Immunology
10.7.4. Toxicology
10.7.5. Other
10.8. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
10.8.1. CROs
10.8.2. Academic and Research Institutes
10.8.3. Pharmaceutical & Biotechnology Companies
10.9. Market Attractiveness Analysis
11. Competition Landscape
11.1. Market Share Analysis, 2022
11.2. Market Structure
11.2.1. Competition Intensity Mapping By Market
11.2.2. Competition Dashboard
11.2.3. Apparent Product Capacity
11.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
11.3.1. Charles River Laboratories
11.3.1.1. Overview
11.3.1.2. Segments and Product
11.3.1.3. Key Financials
11.3.1.4. Market Developments
11.3.1.5. Market Strategy
11.3.2. Envigo
11.3.2.1. Overview
11.3.2.2. Segments and Product
11.3.2.3. Key Financials
11.3.2.4. Market Developments
11.3.2.5. Market Strategy
11.3.3. genOway
11.3.3.1. Overview
11.3.3.2. Segments and Product
11.3.3.3. Key Financials
11.3.3.4. Market Developments
11.3.3.5. Market Strategy
11.3.4. Laboratory Corporation of America Holdings (LabCorp)
11.3.4.1. Overview
11.3.4.2. Segments and Product
11.3.4.3. Key Financials
11.3.4.4. Market Developments
11.3.4.5. Market Strategy
11.3.5. Janvier Labs
11.3.5.1. Overview
11.3.5.2. Segments and Product
11.3.5.3. Key Financials
11.3.5.4. Market Developments
11.3.5.5. Market Strategy
11.3.6. Taconic Biosciences, Inc.
11.3.6.1. Overview
11.3.6.2. Segments and Product
11.3.6.3. Key Financials
11.3.6.4. Market Developments
11.3.6.5. Market Strategy
11.3.7. TransViragen, Inc.
11.3.7.1. Overview
11.3.7.2. Segments and Product
11.3.7.3. Key Financials
11.3.7.4. Market Developments
11.3.7.5. Market Strategy
11.3.8. Biomere
11.3.8.1. Overview
11.3.8.2. Segments and Product
11.3.8.3. Key Financials
11.3.8.4. Market Developments
11.3.8.5. Market Strategy
11.3.9. Cyagen Biosciences
11.3.9.1. Overview
11.3.9.2. Segments and Product
11.3.9.3. Key Financials
11.3.9.4. Market Developments
11.3.9.5. Market Strategy
12. Appendix
12.1. Research Methodology
12.2. Research Assumptions
12.3. Acronyms and Abbreviations
Report Sample is Available
In-depth report coverage is now just a few seconds away
Get FREE Report Sample
Make This Report Your Own
Take Advantage of Intelligence Tailored to your Business Objective
Get a Customized Version
